Abiopharma

News list

TACKETT SHANE R 🟢 acquired 4.1K shares (1 derivative) of ALASKA AIR GROUP, INC. (ALK) Transaction Date: Jun 29, 2026 | Filing ID: 000012

Full text

News bot June 30, 2026, 10:33 p.m.
🔍 TACKETT SHANE R (Executive)

Company: ALASKA AIR GROUP, INC. (ALK)

Report Date: 2026-06-29
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 2
- Total shares acquired: 4,100
- Total shares held: 46,361
Detailed Transactions and Holdings:
- Holds 0 shares of COMMON STOCK (Direct)
  Date: 2026-06-29 | Code: H | shares_owned_after: 43,555.00 | Footnotes: F1
- Holds 0 shares of COMMON STOCK (Direct)
  Date: 2026-06-29 | Code: H | nature_of_ownership: ESOP TRUST | shares_owned_after: 2,806.00 | Footnotes: F2
- Acquired 4,100 shares of RESTRICTED STOCK UNITS (Derivative)
  Date: 2026-06-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,100.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4
Footnotes:
- F1: Includes 178 shares acquired under the Alaska Air Group, Inc. Employee Stock Purchase Plan on April 30, 2026, in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- F2: Common shares held in the Alaska Air Group, Inc. Employee Stock Ownership 401(K) Plan Trust, as of 6/29/2026.
- F3: Each restricted stock unit (RSUs) represents a contingent right to receive one share of ALK common stock.
- F4: The RSUs vest in three annual installments as follows: 1,366 shares on June 29, 2027; 1,367 shares on June 29, 2028; and 1,367 shares on June 29, 2029.